The potential of new tariffs brings near-term uncertainties for British American Tobacco stock. Read more about the positives ...

Q4 2024 Earnings Conference Call April 2, 2025 10:00 AM ETCompany ParticipantsMargaret Brodie - CEOJanis Risbin ...

CG Oncology, Inc.'s promising bladder cancer therapy has strong clinical results, competitive CR rates, and a $69 target ...

M revenue in 2025 with strong margins, military contracts, and Palantir collaboration. Click to read why RCAT is a Strong Buy ...

Discover why DNP's reliable distributions attract income investors and explore why DPG might be a smarter buy right now.

CoreWeave’s 2022 to 2024 financial path is one of hypergrowth, efficiency improvement, and early-stage profitability. In 2022 ...

Will tariffs cause inflation and higher interest rates? Jitania Kandhari discusses how subsidies, sanctions & security ...

BB Seguridade Participações S.A. offers a 9% dividend yield but is overvalued. Click for my look at BBSEY stock and its big ...

Exxon Mobil's stock remains steady year-over-year. Learn why the recent price rise may not last and explore its long-term growth potential in the energy sector. Read why XOM stock is a hold.

Overall, the fourth quarter of 2024 was characterized by resilient labor market dynamics, strong economic growth and sticky ...

Berkshire Hathaway's foresight and $334.2B cash pile position it well for opportunities amid 2025 market turmoil. Read more ...

Rocket Lab's management says backlog is a metric prone to lumpiness: While year-on-year backlog growth was modest at ...